mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.6 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.17 |
0.6 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |